The rate of recurrence has been approximated between 25 and 30% remains elevated among BRCA1/2-positive cancer survivors but remains highly dependent on individual clinical characteristics such as stage at diagnosis, treatment(s), and hormone receptor status6. Here, BRCA1 is linked to cancer.